258
Views
3
CrossRef citations to date
0
Altmetric
Review

Considering potential solutions for limitations and challenges in the health economic evaluation of gene therapies

, , , &
Pages 1145-1158 | Received 08 Feb 2021, Accepted 13 Aug 2021, Published online: 30 Aug 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ahmad Z. Al Meslamani. (2023) Economic benefits of global Collaborative Health technology. Expert Review of Pharmacoeconomics & Outcomes Research 0:0, pages 1-3.
Read now
Mondher Toumi, Omar Dabbous, Samuel Aballéa, Michael F. Drummond, Johann-Matthias Graf von der Schulenburg, Daniel C. Malone, Peter J. Neumann, Sean D. Sullivan & Sean Tunis. (2023) Recommendations for economic evaluations of cell and gene therapies: a systematic literature review with critical appraisal. Expert Review of Pharmacoeconomics & Outcomes Research 23:5, pages 483-497.
Read now

Articles from other publishers (1)

Tingting Qiu, Michal Pochopien, Shuyao Liang, Gauri Saal, Ewelina Paterak, Justyna Janik & Mondher Toumi. (2022) Gene Therapy Evidence Generation and Economic Analysis: Pragmatic Considerations to Facilitate Fit-for-Purpose Health Technology Assessment. Frontiers in Public Health 10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.